繁體
  • 简体中文
  • 繁體中文

熱門資訊> 正文

Movano Health获得纳斯达克批准上市延期

2025-08-29 04:44

  • Movano Health (NASDAQ:MOVE) on Thursday said it received a listing extension from the Nasdaq Hearings Panel on August 27, 2025.
  • Extension requires compliance with Listing Rule 5250(c)(1) by filing Q1 and Q2 2025 10-Qs by September 30, 2025.
  • Must also comply with Listing Rule 5550(a)(2) requiring the maintenance of $1.00 per share bid price, on or before October 30, 2025.
  • Panel decision follows August 19, 2025 hearing reviewing company's compliance plan.
  • Additionally, on August 19, 2025, the company filed a Preliminary Proxy Statement for its Annual Shareholders Meeting to be held on September 26, 2025, at which the company's shareholders will have the opportunity to approve a reverse stock split proposal, the effect of which will allow the company to demonstrate compliance rule within the extension period granted by the panel.
  • MOVE +17.61% after hours to $0.7264
  • Source: Press Release

風險及免責提示:以上內容僅代表作者的個人立場和觀點,不代表華盛的任何立場,華盛亦無法證實上述內容的真實性、準確性和原創性。投資者在做出任何投資決定前,應結合自身情況,考慮投資產品的風險。必要時,請諮詢專業投資顧問的意見。華盛不提供任何投資建議,對此亦不做任何承諾和保證。